european end-to-end CDMO company, pharma services
  • About us
    • History
    • Leaderships
    • Team
    • EU grants
    • Requests for Proposal
    • Sustainability – ESG
    • Bussines strategy
    • Quality policy
    • Virtual Tour
  • Services
    • Drug Substance Manufacturing
    • Fill & Finish
    • Gene to Vial: End-to-End Development
    • Process Development
    • Analytics 
    • Cell Line Development & Banking
  • Science Hub
    • Science News
    • Resources
  • News & Events
    • Press releases
    • Events
    • Content to download
  • Investors
    • Corporate documents
    • Shareholders and shares
    • Periodic reports
    • Current reports
    • Sustainability reports
    • Corporate governance at Mabion
    • Financial data
    • For Investors
    • Calendar
  • Contact us
    • Contact form
    • Contact for investors
    • Contact for media
    • Careers
  • EN
  • Science News
  • Resources

Drug development

stable cell line development

Role of Stable Cell Line in Biopharmaceutical Manufacturing 

Drug development, Drug product, Manufacturing
time to market strategy

Time to Market Strategy – 5 CDMO Tactics to Speed Up Biologic Launches

Biologics, Drug development, Manufacturing
CHO K1 cell line 27 hours

CHO Cell Lines for Recombinant Protein Production

Drug development, Drug product, Manufacturing
leading european cdmo

Leading European CDMO for Drug Product Manufacturing

Drug development, Drug product, Manufacturing
antibodies development best practices

Antibodies Development Best Practices for CDMO Collaboration

Drug development, Manufacturing, Monoclonal antibody
Host Cell Proteins

Qualitative Analysis of Host Cell Proteins using Mass Spectrometry

Analytics, Drug development, Drug product, Drug substance
Biologics CDMO

Biologics CDMO Solutions for the Future of Therapeutics

Biologics, Drug development, Manufacturing
Biologics drugs to be approved in 2024.

Top 5 most expected biologics in 2024

Biologics, Drug development, EMA, FDA, Regulatory
Veterinary Monoclonal Antibodies

Development and regulation of veterinary monoclonals

Biologics, Drug development, Regulatory, Veterinary biologics
Previous 1 2

Contact

Find out how we may support your business.

bd@mabion.eu

Mabion

gen. Mariana Langiewicza 60
95-050 Konstantynów Łódzki
Poland

+48 42 207 78 90

    Mabion
    • Privacy policy
    • Services
    • Investors
    • News&Events
    • Contact us

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Powered by

    Veneo